VAN NOSTRAND ROBERT L
SEC CIK 1225198 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SLS | SELLAS Life Sciences Group, Inc. | Dir | 82.9K | $14.8K | — | 6 | 2022-01-31 | 2026-01-07 |
Most active insiders at SLS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kalin Katherine Bach | Dir | $100.8K | — |
| 2 | Stergiou Angelos M. | Pres, CEO, Dir | — | — |
| 3 | Burns John Thomas | CFO | — | — |
| 4 | CICIC DRAGAN | SVP, Chief Development Off | — | — |
| 5 | Varian John | Dir | — | — |
| 6 | Wasman Jane | Dir | — | — |
| 7 | SCHEINBERG DAVID A | Dir | — | — |
| 8 | VAN NOSTRAND ROBERT L | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-09 | 2026-01-07 | SLS | SELLAS Life Sciences Group, Inc. | VAN NOSTRAND ROBERT L | Dir | A - Grant | $0.00 | +50.0K | 82.9K | +152% | $0 | |
| 2025-06-13 | 2025-06-12 | SLS | SELLAS Life Sciences Group, Inc. | VAN NOSTRAND ROBERT L | Dir | P - Purchase | $1.48 | +10.0K | 20.4K | +96% | +$14.8K | |
| D | 2025-01-14 | 2025-01-10 | SLS | SELLAS Life Sciences Group, Inc. | VAN NOSTRAND ROBERT L | Dir | A - Grant | $0.00 | +12.5K | 22.9K | +120% | $0 |
| D | 2024-01-25 | 2024-01-22 | SLS | SELLAS Life Sciences Group, Inc. | VAN NOSTRAND ROBERT L | Dir | A - Grant | $0.00 | +6,000 | 10.4K | +136% | $0 |
| D | 2023-02-03 | 2023-02-02 | SLS | SELLAS Life Sciences Group, Inc. | VAN NOSTRAND ROBERT L | Dir | A - Grant | $0.00 | +2,500 | 4,400 | +132% | $0 |
| D | 2022-02-01 | 2022-01-31 | SLS | SELLAS Life Sciences Group, Inc. | VAN NOSTRAND ROBERT L | Dir | A - Grant | $0.00 | +1,900 | 1,900 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations